857136C

18:1 BMP (R,R)

sn-(1-oleoyl-2-hydroxy)-glycerol-3-phospho-sn-3′-(1′-oleoyl-2′-hydroxy)-glycerol (ammonium salt), chloroform

• Synonym(e): bis(monoacyl-glycerol)phosphate, lysobisphosphatidic acid; LBPA
• Empirische Formel (Hill-System): C₄₂H₈₂NO₁₀P
• CAS-Nummer: 1246303-13-8
• Molekulargewicht: 792.07
• UNSPSC-Code: 12352211

Eigenschaften

• Assay: >99% (BMP (contains 30% positional isomers), TLC)
• Form: chloroform solution
• Verpackung: pkg of 1 × 1 mL (857136C-5mg)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand 857136C
• Konzentration: 5 mg/mL (857136C-5mg)
• Versandbedingung: dry ice
• Lagertemp.: −20°C
• SMILES String: [H][C@@](COP(OC[C@]([H])(O)COC(CCCCCCC/C=C\CCCCCCCC)=O)([O-])=O)(O)COC(CCCCCCC/C=C\CCCCCCCC)=O.[NH4+]

Beschreibung

Allgemeine Beschreibung

18:1 BMP (R,R)/Lysobisphosphatidic acid (LBPA) is an unconventional phospholipid. It is usually present in late endosomes.[1] It is also termed as bis(monoacyl-glycerol)phosphate.[2][1]

Biochem./physiol. Wirkung

18:1 BMP (R,R)/Lysobisphosphatidic acid (LBPA) can modulate endosomal cholesterol levels. It participates in cholesterol transport. LBPA helps to regulate the cholesterol storage capacity of endosomes.[1]

Verpackung

5 mL Clear Glass Sealed Ampule (857136C-5mg)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Piktogramme: GHS06,GHS08
• Signalwort: Danger
• H-Sätze: H302,H315,H319,H331,H336,H351,H361d,H372,H412
• P-Sätze: P201 - P273 - P301 + P312 + P330 - P302 + P352 - P304 + P340 + P311 - P308 + P313
• Gefahreneinstufungen: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• Zielorgane: Central nervous system, Liver,Kidney
• Lagerklassenschlüssel: 6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
• WGK: WGK 3
• Flammpunkt (°F): does not flash
• Flammpunkt (°C): does not flash